Copyright
©2010 Baishideng.
World J Gastroenterol. Jul 7, 2010; 16(25): 3144-3152
Published online Jul 7, 2010. doi: 10.3748/wjg.v16.i25.3144
Published online Jul 7, 2010. doi: 10.3748/wjg.v16.i25.3144
Table 4 Performance of individual assays in both risk populations in the theoretical analysis aiming to avoid duodenal biopsy when serology is negative
| Individual serology tests | High-risk | Low-risk | ||
| Biopsy avoided (%) | Missed CD cases (n) | Biopsy avoided (%) | Missed CD cases (n) | |
| IgA a-tTG | 61.5 | 3 | 95.4 | 4 |
| IgA a-DGP | 57.1 | 1 | 93.6 | 3 |
| IgG a-DGP | 62.7 | 3 | 96.7 | 5 |
| DGP Dual | 61.5 | 2 | 96.0 | 4 |
| DGP/tTG Screen | 56.5 | 0 | 91.3 | 3 |
| AAA | 62.7 | 8 | 90.3 | 8 |
- Citation: Sugai E, Moreno ML, Hwang HJ, Cabanne A, Crivelli A, Nachman F, Vázquez H, Niveloni S, Argonz J, Mazure R, Motta GL, Caniggia ME, Smecuol E, Chopita N, Gómez JC, Mauriño E, Bai JC. Celiac disease serology in patients with different pretest probabilities: Is biopsy avoidable? World J Gastroenterol 2010; 16(25): 3144-3152
- URL: https://www.wjgnet.com/1007-9327/full/v16/i25/3144.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i25.3144